Abstract
A review of patients treated for malignant and benign parotid tumors in a 10-year period (1991–2000) in the Pomeranian County of Poland revealed 417 new cases. The age-standardized incidence rate was 0.23 and 1.35 per 100,000 inhabitants for malignant and benign tumors, respectively. The following data were collected: age, sex, place of living, education, job, smoking, symptoms, duration of symptoms at the time of diagnosis, result of histopathological tumor examination, tumor size, TNM staging and distant metastases. The results were divided into two parts: malignant neoplasms and benign neoplasms. The most common malignant neoplasms were carcinomas (96.8%), and among them the most numerous were mucoepidermoid carcinoma (22.2%), carcinoma in pleomorphic adenoma (20.6%) and adenoid cystic carcinoma (15.9%). The most common benign neoplasms were adenomas (95.5%), most frequently pleomorphic adenoma (65.5%) and adenolymphoma (24.0%), but rarely basal cell adenoma (4.2%). We also observed a steady increase in the number of benign parotid tumors in the examined period of time.
Similar content being viewed by others
References
Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, Spiro RH (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69:615–619
Auclair DL, Ellis GL, Gnepp DR, Wenig BM, Janney CG (1991) Salivary gland neoplasms: general considerations. In: Ellis GL, Auclair PL, Gnepp OR (eds) Surgical pathology of the salivary glands. Saunders, Philadelphia, pp 135–164
Bouquot JE, Beard CM, Weiland LH, Kurland LT, Ballard DJ (1987) The first epidemiologic analysis of benign and malignant salivary neoplasms showing increase benign and decreasing malignant incidence rates 1935–1984. Presented at the Annual Meeting of the American Academy of Oral Pathology No 31, Phoenix
Cancer Registration in Norway (1961) The incidence of cancer in Norway 1953–1958. Norwegian Cancer Society, Oslo
Charabi S, Balle V, Charabi B, Nielsen P, Thompsen J (2000) Surgical outcome in malignant parotids. Acta Otolaryngol [Suppl 543]:251–253
Cox B, Taylor K, Treasure E (1995) Trends in oral cancer by subsite in New Zealand. Eur J Cancer Oral Oncol 31B:113–117
Davies JNP, Dodge OG, Burkitt DP (1964) Salivary gland s in Uganda. Cancer 17:1310–1322
Dietz A, Barme B (1993) Zur Epidemiologie der Parotisen. Eine Fallkontrollstudie. HNO 41:83–90
Doll R, Muir CS, Waterhouse JAH (eds) (1970) Cancer in five continents, vol II. UICC and Springer, New York
Eneroth CM (1971) Salivary glands in the parotid gland, submandibular gland, and the palate region. Cancer 27:1415–1418
Eveson JW, Cawson RA (1986) Warthin’s (cystadenolymphoma) of salivary glands. A clinicopathologic investigation of 278 cases. Oral Surg Oral Med Oral Pathol 61:256–262
Gunn A, Parrott NR (1988) Parotid tumors: a review of parotid tumor surgery in the Northern Regional Health Authority of the United Kingdom 1978–1982. Br J Surg 75:1144–1146
Hazen RW, Pifer JW, Toyooka ET, Livingwood J, Hampelmann LH (1966) Neoplasms following irradiation of the head. Cancer Res 26:305–311
Horn Ross PL, West DW, Brown SR (1991) Recent trends in the incidence of salivary gland cancer. Int J Epidemiol 20:628–633
Koivunen P, Suutala L, Schorsch I, Jokinen K, Alho OP (2002) Malignant epithelial salivary gland s in northern Finland: incidence and clinical characteristics. Eur Arch Otorhinolaryngol 259:146–149
Kowalska B, Stankiewicz C, Mikaszewski B, Brzoznowski W (1999) Regional and distant metastases of malignant s of parotid gland (in Polish). Otolaryngol Pol [Suppl 30]:598–600
Leverstein H, van der Wal JE, Tiwari RM, Tobi H, van der Waal I, Mehta DM, Snow GB (1998) Malignant epithelial parotid gland tumors: analysis and results in 65 previously untreated patients. Br J Surg 85:1267–1272
Lewis DR, Webb AJ, Lott MF, Brookes ST, Farndon JR (1999) Improving cytological diagnosis and surgical management of parotid adenolymphoma. Br J Surg 86:1275–1279
LiVolsi VA, Merino MJ (1987) Histopathology of salivary glands. In: Ariyan S (ed) Cancer of the head and neck. Mosby, Saint Louis
Loke YW (1967) Salivary gland tumors in Malaya. Br J Cancer 21:665–674
Monk JS, Church JS (1992) Warthin’s tumor. Arch Otolaryngol Head Neck Surg 118:477–478
Muir C (ed) (1992) Cancer incidence in five continents, vol VI. IARC Scientific Publications, Lyon
Numata T, Muto H, Shiba K, Nagata H, Terada N, Konno A (2000) Evaluation of the validity of the 1997 International Union Against Cancer TNM classification of major salivary gland carcinoma. Cancer 89:1664–1669
Östman J, Anneroth G, Gustafsson H, Tavelin B (1997) Malignant salivary gland tumors in Sweden 1960–1998. An epidemiological study. Oral Oncol 33:169–176
Ożdziński W, Kozłowski J, Barciński G (1989) Salivary gland tumors treated at the Otolaryngology Clinic, Medical Academy, Gdańsk in 1969–1988 (in Polish). Otolaryngol Pol [Suppl 24]:318–320
Pacheco Ojeda L, Domeisen H, Narvaez M, Tixi R, Vivar N (2000) Malignant salivary glands in Quito, Ecuador. ORL 62:296–302
Seanger EL, Silvermann FN, Sterling TD, Turner ME (1960) Neoplasia following therapeutic radiation for benign conditions in childhood. Radiology 74:889–904
Seifert G, Okabe H, Caselitz J (1986) Epithelial salivary gland s in children and adolescents. Analysis of 80 cases (salivary gland register 1965–1984). ORL 48:137–149
Seifert G, Sobin LH (1991) World Health Organization international histological classification of tumors. Histological typing of salivary gland tumors, 2nd edn. Springer, New York Berlin Heidelberg
Sikorowa L, Meyza J (1989) The tumors of salivary glands (in Polish). PZWL, Warsaw
Sobin LH, Wittekind C (eds) (1997) International Union against Cancer: TNM classification of malignant tumors, 5th edn. Willey-Liss, New York Chicester Weinheim
Spiro IJ, Wang CC, Montgomery WW (1993) Carcinoma of the parotid gland. Analysis of treatment and patterns of failure after combined surgery and radiation therapy. Cancer 71:2699–2705
Spiro RH (1986) Salivary neoplasms: overwiew of a 35-year experience with 2,807 patients. Head Neck Surg 8:177–184
Spitz MR, Fueger JJ, Goepfert H, Newell GR (1990) Salivary gland cancer: a case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg 116:1163–1166
Takeichi N, Hirose F, Yamamoto H, Ezaki H, Fujikura T (1983) Salivary gland s in atomic bomb survivors, Hiroshima, Japan. Cancer 52:377–385
Wallace AC, MacDougall JT, Hildes JA, Lederman JM (1963) Salivary glands in Canadian Eskimos. Cancer 16:1338–1353
William JK, McCaffrey TV, Olsen KD, Lewis JE (1991) Primary parotid malignancies. Arch Otolaryngol Head Neck Surg 117:307–315
Yamashita T, Tomoda K, Kumazawa T (1992) The usefulnes of partial parotidectomy for benign parotid gland s: a retrospective study of 306 cases. Acta Otolaryngol [Suppl 500]:113–116
Yoo GH, Eisele DW, Askin FB, Drieben JS, Johns ME (1994) Warthin’s: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope 104:799–803
Zatoński W, Tyczyński J (1997) Cancer in Poland in 1994. Poligraphic Study of Oncology Center, Warsaw, pp 57–73
Acknowledgements
The authors thank Prof. J. Jordan from the ENT Department of the Municipal Hospital of Gdynia, Dr. W. Martyński from the ENT Department of the Hospital of F. Ceynowa in Wejherowo and Dr. L. Popiel from the ENT Department of the Hospital of St. Adalbert in Gdansk for kindly making the clinical data used in this study accessible to us.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Przewoźny, T., Stankiewicz, C. Neoplasms of the parotid gland in northern Poland, 1991–2000: an epidemiologic study. Eur Arch Otorhinolaryngol 261, 369–375 (2004). https://doi.org/10.1007/s00405-003-0698-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-003-0698-4